tradingkey.logo
搜索

Utah Medical Products Inc

UTMD
添加自选
74.750USD
-0.260-0.35%
收盘 09-24 16:00(美东)
237.71M总市值
22.15市盈率 TTM

关于 Utah Medical Products Inc 公司

Utah Medical Products, Inc. develops, manufactures and markets a broad range of disposable and reusable specialty medical devices. The Company has a particular interest in healthcare for women and their babies. The Company’s broad range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians’ offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a patented uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device. The Company produces medical devices for blood pressure monitoring and blood management, electrosurgery, labor and delivery, neonatal intensive care, urological care and women’s pelvic health.

Utah Medical Products Inc 简介

公司代码UTMD
公司名称Utah Medical Products Inc
上市日期Dec 01, 1982
CEOCornwell (Kevin L)
员工数量155
证券类型Ordinary Share
年结日Dec 01
公司地址7043 S 300 West
城市MIDVALE
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编84070
电话18015215301
网址http://www.utahmed.com
公司代码UTMD
上市日期Dec 01, 1982
CEOCornwell (Kevin L)

Utah Medical Products Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Kevin L. Cornwell
Mr. Kevin L. Cornwell
Chairman of the Board, President, Chief Executive Officer, Secretary
Chairman of the Board, President, Chief Executive Officer, Secretary
188.47K
--
Mr. Kevin L. Cornwell
Mr. Kevin L. Cornwell
Chairman of the Board, President, Chief Executive Officer, Secretary
Chairman of the Board, President, Chief Executive Officer, Secretary
188.47K
--
Mr. Kevin L. Cornwell
Mr. Kevin L. Cornwell
Chairman of the Board, President, Chief Executive Officer, Secretary
Chairman of the Board, President, Chief Executive Officer, Secretary
188.47K
--
Mr. Paul O. Richins
Mr. Paul O. Richins
Independent Director
Independent Director
21.14K
-0.47%
Mr. Paul O. Richins
Mr. Paul O. Richins
Independent Director
Independent Director
21.14K
-0.47%
Mr. Paul O. Richins
Mr. Paul O. Richins
Independent Director
Independent Director
21.14K
-0.47%
Dr. James H. Beeson, M.D., Ph.D.
Dr. James H. Beeson, M.D., Ph.D.
Independent Director
Independent Director
13.13K
--
Dr. James H. Beeson, M.D., Ph.D.
Dr. James H. Beeson, M.D., Ph.D.
Independent Director
Independent Director
13.13K
--
Dr. James H. Beeson, M.D., Ph.D.
Dr. James H. Beeson, M.D., Ph.D.
Independent Director
Independent Director
13.13K
--
Mr. Ernst G. Hoyer
Mr. Ernst G. Hoyer
Lead Independent Director
Lead Independent Director
5.00K
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Kevin L. Cornwell
Mr. Kevin L. Cornwell
Chairman of the Board, President, Chief Executive Officer, Secretary
Chairman of the Board, President, Chief Executive Officer, Secretary
188.47K
--
Mr. Kevin L. Cornwell
Mr. Kevin L. Cornwell
Chairman of the Board, President, Chief Executive Officer, Secretary
Chairman of the Board, President, Chief Executive Officer, Secretary
188.47K
--
Mr. Kevin L. Cornwell
Mr. Kevin L. Cornwell
Chairman of the Board, President, Chief Executive Officer, Secretary
Chairman of the Board, President, Chief Executive Officer, Secretary
188.47K
--
Mr. Paul O. Richins
Mr. Paul O. Richins
Independent Director
Independent Director
21.14K
-0.47%
Mr. Paul O. Richins
Mr. Paul O. Richins
Independent Director
Independent Director
21.14K
-0.47%
Mr. Paul O. Richins
Mr. Paul O. Richins
Independent Director
Independent Director
21.14K
-0.47%

常见问题

Utah Medical Products Inc的前五大股东是谁?

Utah Medical Products Inc 的前五大股东如下:Mr. Kevin L. Cornwell

有多少机构持有Utah Medical Products Inc(UTMD)的股份?

截至2026Q1,共有253家机构持有Utah Medical Products Inc的股份,合计持有的股份价值约为2.44M,占公司总股份的76.75%。与2025Q4相比,机构持股有所增加,增幅为-74096.00。

哪个业务部门对Utah Medical Products Inc的收入贡献最大?

在2026Q1,Gynecology/Electrosurgery/Urology业务部门对Utah Medical Products Inc的收入贡献最大,创收4.28M,占总收入的50.18%。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有